The Association of the British Pharmaceutical Industry (ABPI) responds to the Comprehensive Spending Review….reports Asian Lite News
“We’re pleased that the Government has said it is committed to protecting the science budget in real terms,” said Alison Clough, Acting CEO of the ABPI. This recognises the importance that world-leading science brings to the economy and UK patients.
“We need more detail about £1.5billion of the existing science budget being earmarked for a new ‘global challenges fund’ and any impact this may have on the current research environment. Promising to protect the budget, while at the same time adding new funding commitments could mean a cut in real terms.
“The announcement of cuts to BIS, changes in higher education funding, the implementation of the Nurse review and the move from business grants to loans from Innovate UK, may cause upheaval and impact on the UK’s global competitiveness in science and innovation. We want to work with the Government to address these issues on behalf of our industry.”